Session » Abstracts: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes I: Breathe (ILD/Pulmonary) (1746–1751)
- 10:00AM-10:15AM
-
Abstract Number: 1746
Inflammatory- and Fibrosis-Related Biomarkers and Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk
- 10:15AM-10:30AM
-
Abstract Number: 1747
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis: A matched cohort study
- 10:30AM-10:45AM
-
Abstract Number: 1748
Effect of Air Pollution on Disease Activity in Patients with Rheumatoid Arthritis
- 10:45AM-11:00AM
-
Abstract Number: 1749
External validation of a combined clinical and genetic risk score for the identification of interstitial lung disease in rheumatoid arthritis
- 11:00AM-11:15AM
-
Abstract Number: 1750
Urinary Proteomic Signature Identifies Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease